Naranda J, Ekart R, Pečovnik-Balon B
Faculty of Medicine, University of Maribor, Maribor, Slovenia.
J Int Med Res. 2011;39(3):978-87. doi: 10.1177/147323001103900333.
Chronic kidney disease-mineral and bone disease (CKD-MBD) is associated with uraemic bone disease, vascular calcification, reduced quality of life and reduced survival. This study evaluated the efficacy of parathyroidectomy (PTX) with autotransplantation in improving short-term and long-term outcomes. Dialysis patients who underwent PTX showed significantly more favourable biochemical parameters after PTX. These changes were accompanied by a lower coronary artery calcification score, reduced thickness of the intimae media and comparable bone mineral density measures compared with control dialysis patients who did not undergo PTX. Despite the risk of a substantially lower intact parathyroid hormone level postoperatively that might lead to adynamic bone disease, none of the patients reported clinical signs of this disease, such as bone pain or fractures. In conclusion, PTX with autotransplantation led to improvement of CKD-MBD so may be considered in patients with secondary hyperparathyroidism that is resistant to treatment with vitamin D analogues and calcimimetics.
慢性肾脏病-矿物质和骨异常(CKD-MBD)与尿毒症性骨病、血管钙化、生活质量下降及生存率降低相关。本研究评估了甲状旁腺切除术(PTX)联合自体移植在改善短期和长期预后方面的疗效。接受PTX的透析患者术后生化指标改善更为显著。与未接受PTX的对照透析患者相比,这些变化伴随着较低的冠状动脉钙化评分、内膜中层厚度降低以及相当的骨矿物质密度测量值。尽管术后完整甲状旁腺激素水平大幅降低可能导致动力缺失性骨病,但无一例患者报告有该疾病的临床症状,如骨痛或骨折。总之,PTX联合自体移植可改善CKD-MBD,因此对于对维生素D类似物和拟钙剂治疗耐药的继发性甲状旁腺功能亢进患者可考虑采用该治疗方法。